Literature DB >> 2993488

Identification of cross-reacting glycoproteins of four herpesviruses by Western blotting.

B W Snowden, I W Halliburton.   

Abstract

Monospecific rabbit antisera against purified herpes simplex virus type 1 (HSV-1) gB, gC or gD antigens or polyvalent rabbit antiserum against equine herpesvirus type 1 (EHV-1)-infected cells was used in Western blotting to identify antigenically related proteins in cells infected with HSV-1, HSV-2, bovine mammillitis virus or EHV-1. Monomeric and oligomeric polypeptides related to HSV-1 gB were found in cells infected with each of the four herpesviruses. The gC antiserum was specific for HSV-1 and the gD antiserum reacted only with polypeptides in HSV-1- or HSV-2-infected cells. Neither gC nor gD antiserum revealed the existence of oligomeric forms of the glycoproteins with the single exception of HSV-1 strain KOS which had a heat-unstable high molecular weight form gD. The EHV-1 antiserum reacted with high molecular weight polypeptides of the same mobility as the oligomeric form of gB in cells infected with each of the four herpesviruses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993488     DOI: 10.1099/0022-1317-66-9-2039

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Herpes simplex virus type 1 glycoprotein E is not indispensable for viral infectivity.

Authors:  H Neidhardt; C H Schröder; H C Kaerner
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

2.  Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1.

Authors:  G P Allen; M R Yeargan
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  Homology between feline herpesvirus-1 and canine herpesvirus.

Authors:  P A Rota; R K Maes
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Pseudorabies virus gene encoding glycoprotein gIII is not essential for growth in tissue culture.

Authors:  A K Robbins; M E Whealy; R J Watson; L W Enquist
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

5.  HSV-1 gB and VZV gp-II crossreactive antibodies in human sera.

Authors:  J E Kühn; K Klaffke; K Munk; R W Braun
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.

Authors:  E M Cantin; R Eberle; J L Baldick; B Moss; D E Willey; A L Notkins; H Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Detection of antibodies against equine herpesvirus types 1 and 4 by using recombinant protein derived from an immunodominant region of glycoprotein B.

Authors:  R Sinclair; M M Binns; E D Chirnside; J A Mumford
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

8.  Characterization of an equine herpesvirus type 1 gene encoding a glycoprotein (gp13) with homology to herpes simplex virus glycoprotein C.

Authors:  G P Allen; L D Coogle
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  The characterization of equine herpes virus-1-infected cell polypeptides recognized by equine lymphocytes.

Authors:  C G Bridges; N Ledger; N Edington
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

Review 10.  Immunoblotting and dot blotting.

Authors:  D I Stott
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.